BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
650 results:

  • 1. Donor
    Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
    Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. HLA Gene Polymorphisms in Romanian Patients with Chronic Lymphocytic leukemia.
    Tizu M; Calenic B; Hârza M; Cristea BM; Maruntelu I; Caragea AM; Talangescu A; Dima A; Constantinescu AE; Constantinescu I
    Genet Res (Camb); 2024; 2024():8852876. PubMed ID: 38449839
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HLA peptide-binding pocket diversity modulates immunological complications after cord blood transplant in acute leukaemia.
    Boukouaci W; Rivera-Franco MM; Volt F; Lajnef M; Wu CL; Rafii H; Cappelli B; Scigliuolo GM; Kenzey C; Ruggeri A; Rocha V; Gluckman E; Tamouza R
    Br J Haematol; 2024 May; 204(5):1920-1934. PubMed ID: 38380743
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Allogeneic CAR-T cells with of hla-a/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies.
    Chen X; Tan B; Xing H; Zhao X; Ping Y; Zhang Z; Huang J; Shi X; Zhang N; Lin B; Cao W; Li X; Zhang X; Li L; Jiang Z; Zhang M; Li W; Liu M; Du B; Zhang Y
    Cancer Immunol Immunother; 2024 Jan; 73(1):13. PubMed ID: 38231412
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of HLA antibody identification methods for the selection of platelet products for HLA-mediated platelet refractory patients.
    Pedini P; Hubert L; Baudey JB; Etienne JM; Basire A; Vey N; Chiaroni J; Chabrières C; Ladaique P; Picard C
    HLA; 2024 Jan; 103(1):e15276. PubMed ID: 37947374
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
    Molvi Z; Klatt MG; Dao T; Urraca J; Scheinberg DA; O'Reilly RJ
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775115
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. hla-a*02:06 allele may be susceptible to myelodysplastic syndrome in Zhejiang Han population, China.
    Chen N; Wang F; Zhao Y; Dong L; Wang W; Zhang W; He J; Zhu F
    Int J Immunogenet; 2023 Oct; 50(5):233-242. PubMed ID: 37485595
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gene expression and TCR amino acid sequences selected by hla-a02:01-restricted CTLs specific to HTLV-1 in ATL patients.
    Kusuda M; Nakasone H; Yoshimura K; Okada Y; Tamaki M; Matsuoka A; Ishikawa T; Meno T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Gomyo A; Tanihara A; Kimura SI; Kako S; Kanda Y
    Br J Haematol; 2023 Aug; 202(3):578-588. PubMed ID: 37317804
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
    Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; Calabrò M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies.
    Chervin AS; Stone JD; Konieczna I; Calabrese KM; Wang N; Haribhai D; Dong F; White MK; Rodriguez LE; Bukofzer GT; Ellis PA; Cosgrove C; Hecquet C; Clarin JD; Palma JP; Reilly EB
    Mol Cancer Ther; 2023 Aug; 22(8):903-912. PubMed ID: 37294945
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Donor Selection for Allogeneic Hematopoietic Cell Transplantation.
    Fleischhauer K; Tran TH; Meisel R; Mytilineos J; Dreger P; Kröger N
    Dtsch Arztebl Int; 2023 Apr; 120(15):261-268. PubMed ID: 36949660
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Frequency of transfusion transmissible infections among blood donors of Rawalpindi District, Pakistan.
    Ghazanfar S; Hassan S; Shahid Z; Khan MS; Malik AR; Bhutta HS; Ikram N; Khan MS
    Afr Health Sci; 2022 Sep; 22(3):590-598. PubMed ID: 36910375
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
    Zhang Y; Ye C; Zhu H; Zhuang Y; Chen S; Weng Y; Ren J; Luo X; Zheng J; Zheng X; Li J; Lan L; Xie Y; Han Z; Hu J; Yang T
    Front Immunol; 2022; 13():1091188. PubMed ID: 36761162
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of the HLA Immunopeptidome on Survival of leukemia Patients After Unrelated Donor Transplantation.
    Crivello P; Arrieta-Bolaños E; He M; Wang T; Fingerson S; Gadalla SM; Paczesny S; Marsh SGE; Lee SJ; Spellman SR; Bolon YT; Fleischhauer K
    J Clin Oncol; 2023 May; 41(13):2416-2427. PubMed ID: 36669145
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Loss of heterozygosity leading to incorrect HLA typing for platelet-transfusion refractory patient.
    Horwath M; Tvrdik T; Saxe D; Deeb KK; Roback JD; Gebel HM; Bray RA; Sullivan HC
    Transfusion; 2023 Jan; 63(1):263-268. PubMed ID: 36426572
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
    Tanaka Y; Sato T; Yagishita N; Yamauchi J; Araya N; Aratani S; Takahashi K; Kunitomo Y; Nagasaka M; Kanda Y; Uchimaru K; Morio T; Yamano Y
    Front Immunol; 2022; 13():993025. PubMed ID: 36081501
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HLA homozygosity is associated with Non-Hodgkin lymphoma.
    Roark CL; Ho BE; Aubrey MT; Anobile C; Israeli S; Phang TL; Braxton D; Ho AP; Freed BM
    Hum Immunol; 2022 Oct; 83(10):730-735. PubMed ID: 35953408
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Association of molecular genetic polymorphism of KIR-HLA systems with acute leukemia in Southern Chinese Han].
    Zhen J; Yang Z; Deng Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):499-504. PubMed ID: 35598265
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation.
    Kanda J; Hirabayashi S; Yokoyama H; Kawase T; Tanaka H; Uchida N; Taniguchi S; Takahashi S; Onizuka M; Tanaka M; Sugio Y; Eto T; Kanda Y; Kimura T; Ichinohe T; Atsuta Y; Morishima S;
    Transplant Cell Ther; 2022 Jul; 28(7):398.e1-398.e9. PubMed ID: 35577322
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.